CX3CR1 and prostate cancer: Follow up studies in prostate cancer cell lines show that they express CX3CR1, the receptor enhances migration in a scratch wound assay, and migration is dampened by CX3CR1 knock-down or by inhibitors of the Src/FAK pathway.